跳至主要内容
临床试验/EUCTR2006-006221-77-GB
EUCTR2006-006221-77-GB进行中(未招募)1 期

Warfarin Anticoagualtion for liver fibrosis in patients transplanted for hepatitis C virus infection. - WAFT-C

Clinical Research office, Faculty of Medicine, Imperial College London0 个研究点目标入组 10 人开始时间: 2007年5月30日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. HCV infection.
  • 2. Age >17.
  • 3. Liver transplant within previous 4 months.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Patients requiring anticoagulation for existing clinical indications.
  • 2. Standard contraindications to anticoagulation (active peptic ulcer disease, past history of haemorrhagic stroke, thrombocytopaenia (Platelets count < 90 x109 /L).
  • 3. Large oesophageal varices persisting post-transplant.
  • 4. Known cerebrovascular abnormalities.
  • 5. HIV antibody positive.
  • 6. Baseline fibrosis score of 2 or greater.

研究者

发起方
Clinical Research office, Faculty of Medicine, Imperial College London

相似试验